Dr. Hamed A. Daw, MD

Dr. Daw practices at Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Daw's NPI, 1467404533, was assigned on May 17, 2006. Dr. Daw holds Ohio license 35077499.

Dr. Daw's primary practice is Fairview Hospital, at 18101 Lorain Avenue, Cleveland, OH 44111 in Cuyahoga County. The practice phone is (216) 476-7000.

Dr. Daw's primary practice is Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Daw is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Daw to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daw practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Daw's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Daw is licensed in Ohio.

CMS data shows 760 Medicare services from Dr. Daw across 10 procedure codes in 2024, for 321 Medicare patients. Medicare paid $44,956 for them.

CMS counts 321 Medicare patients who saw Dr. Daw in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daw's median patient age at 69, with 61% women.

In 2024, Dr. Daw wrote 1,204 Medicare Part D claims for 220 patients. 72% of them were for generic drugs. CMS names the drug for 1,022 of them, across 23 drugs with 11 or more claims each, at $2,934,769 in total drug cost. In 2023, CMS named 1,020 claims across 24 drugs.

Dr. Daw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Daw as offering telehealth.

Dmand AI links 64 papers to Dr. Daw, published from 2011 to 2024. 2018 was the busiest year, with 11. The most frequent topics are Anticoagulants, Pyrazoles and Rivaroxaban. Dr. Daw has published most often in Cureus. Dr. Daw's most frequent co-authors are Timothy P. Spiro, MD, Sidra Khalid, MD and Fahrettin Covut, MD.

CMS Open Payments shows 3 general payments to Dr. Daw from 3 drug and device companies from 2016 to 2024. Education make up the largest share, 71% of the total. Seagen Inc. paid the most, $34.